Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
per week
for 24 weeks
// //

Edesa Biotech Inc NASDAQ: EDSA-Q

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 6.10
Day High 6.53
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Edesa Biotech Inc. is a biopharmaceutical company. It is focused on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company's product pipeline consists of EB01, EB02 and EB04 which are in clinical stage. Edesa Biotech Inc., formerly known as Stellar Biotechnologies Inc., is based in TORONTO.


Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Strong Buy


A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.


A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Edesa Biotech Extends COVID-19 Clinical Study to Poland
AccessWire - Thu Nov 4, 7:00AM CDT
AccessWire - PRTGAM
Thu Nov 4, 7:00AM CDT
- Expansion to European Union country follows favorable Phase 2 results - Company focusing on critically ill hospitalized patients TORONTO, ON / ACCESSWIRE / November 4, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical...
Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients
AccessWire - Mon Sep 20, 7:00AM CDT
AccessWire - PRTGAM
Mon Sep 20, 7:00AM CDT
- Study unblinded due to strong efficacy signal for 28-day mortality endpoint - Critically ill patients demonstrated a 68.5% reduction in the risk of dying when treated with EB05 over Standard of Care - Data monitoring board recommends...
Edesa Biotech to Present at the H.C. Wainwright Global Investment Conference
AccessWire - Thu Sep 9, 6:00AM CDT
AccessWire - PRTGAM
Thu Sep 9, 6:00AM CDT
TORONTO, ON / ACCESSWIRE / September 9, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that Dr. Par Nijhawan, Chief Executive Officer, will...
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 6.08 +3.95% increase
on 11/24/21
Period Open:8.22
Price movement based on the high, low and last over the given period.
8.95 -29.39% decrease
on 11/03/21
-1.90 (-23.11%) decrease
since 10/29/21
3-Month 5.20 +21.54% increase
on 08/31/21
Period Open:5.20
Price movement based on the high, low and last over the given period.
12.00 -47.33% decrease
on 09/20/21
+1.12 (+21.54%) increase
since 08/30/21
52-Week 4.05 +55.86% increase
on 01/04/21
Period Open:5.27
Price movement based on the high, low and last over the given period.
12.00 -47.33% decrease
on 09/20/21
+1.05 (+19.92%) increase
since 11/27/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies